UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical cancer research, ISSN 1078-0432, 09/2005, Volume 11, Issue 18, pp. 6713 - 6721
CTL | Gemcitabine | immune suppression | Suppressor cells | Gene therapy | Lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Immunotherapy - methods | Spleen - immunology | Genetic Vectors - administration & dosage | Apoptosis - drug effects | Deoxycytidine - pharmacology | Antineoplastic Agents - therapeutic use | Spleen - drug effects | Necrosis | CD4-Positive T-Lymphocytes - immunology | Neoplasms, Experimental - pathology | T-Lymphocytes, Cytotoxic - drug effects | Deoxycytidine - therapeutic use | Flow Cytometry | Time Factors | Neoplasms, Experimental - immunology | Adenoviridae - genetics | Interferon-beta - genetics | Killer Cells, Natural - immunology | Female | Antineoplastic Agents - pharmacology | Spleen - pathology | T-Lymphocytes, Cytotoxic - immunology | Cell Line | CD11b Antigen - immunology | Mice, Inbred C57BL | Neoplasms, Experimental - therapy | Receptors, Chemokine - immunology | Genetic Vectors - genetics | B-Lymphocytes - drug effects | Animals | B-Lymphocytes - immunology | Analysis of Variance | CD8-Positive T-Lymphocytes - drug effects | Cell Line, Tumor | Lymphocyte Count | Killer Cells, Natural - drug effects | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Deoxycytidine - analogs & derivatives | Genetic Therapy - methods | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 08/2008, Volume 123, Issue 3, pp. 552 - 560
Prostate cancer | Genistein | Tumor suppressor gene | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | PTEN Phosphohydrolase - drug effects | Prostatic Neoplasms - metabolism | Deubiquitinating Enzyme CYLD | CpG Islands - drug effects | Humans | Male | NF-kappa B - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Genes, Tumor Suppressor - drug effects | Genes, p53 - drug effects | Prostatic Neoplasms - genetics | Chromatin Immunoprecipitation | Forkhead Transcription Factors - metabolism | Sirtuin 1 | Antimetabolites, Antineoplastic - pharmacology | Electrophoretic Mobility Shift Assay | Gene Expression Regulation, Neoplastic - drug effects | Chromones - pharmacology | Anticarcinogenic Agents - pharmacology | Hydroxamic Acids - pharmacology | Phytoestrogens - pharmacology | Prostatic Neoplasms - drug therapy | PTEN Phosphohydrolase - genetics | Tumor Suppressor Proteins - metabolism | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | PTEN Phosphohydrolase - metabolism | Azacitidine - analogs & derivatives | Down-Regulation - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Histones - drug effects | Gene Expression Regulation - drug effects | Up-Regulation - drug effects | Azacitidine - pharmacology | Acetylation - drug effects | Methylation - drug effects | Genistein - pharmacology | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Histones - metabolism | Forkhead Box Protein O3 | Sirtuins - metabolism | NF-kappa B - drug effects | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 04/2012, Volume 130, Issue 8, pp. 1715 - 1725
senescence | tumor suppressor gene p16 | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Cellular Senescence - genetics | Gene Expression - drug effects | Humans | Cellular Senescence - drug effects | Cellular Senescence - physiology | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Neoplasms - prevention & control | Cyclin-Dependent Kinase Inhibitor p16 - physiology | Tumor Suppressor Protein p53 - genetics | Tumor Suppressor Protein p53 - physiology | Cell Cycle Checkpoints | Telomere Shortening | Neoplasms - genetics | Retinoblastoma Protein - genetics | Antineoplastic Agents - pharmacology | Neoplasms - physiopathology | Retinoblastoma Protein - physiology | Transcription factors | Senescence | Kinases | Cell cycle | Index Medicus | Tumor suppressor gene p16
Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 08/2017, Volume 20, Issue 7, pp. 1692 - 1704
ferroptosis | NRF2 | NOX | precision medicine | iron | ddp4 | ACSL4 | SLC7A11 | TP53 | lipid peroxidation | Life Sciences & Biomedicine | Science & Technology | Cell Biology | RNA, Small Interfering - genetics | Dipeptidyl Peptidase 4 - metabolism | Nitriles - pharmacology | Tumor Suppressor Protein p53 - antagonists & inhibitors | Apoptosis - drug effects | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Apoptosis - genetics | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Tumor Suppressor Protein p53 - genetics | Pyrrolidines - pharmacology | Cell Nucleus - metabolism | Colorectal Neoplasms - drug therapy | Injections, Subcutaneous | Cell Membrane - pathology | Antineoplastic Agents - pharmacology | Cell Membrane - metabolism | Cell Membrane - drug effects | Adamantane - analogs & derivatives | Caco-2 Cells | Adamantane - pharmacology | Colorectal Neoplasms - enzymology | Signal Transduction | HCT116 Cells | Dipeptidyl Peptidase 4 - genetics | Tumor Suppressor Protein p53 - deficiency | Iron - metabolism | Piperazines - pharmacology | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Mice | Cell Nucleus - drug effects | Colorectal Neoplasms - pathology | Lipid Peroxidation | RNA, Small Interfering - metabolism | Index Medicus | Life Sciences | Biochemistry, Molecular Biology | Cancer
Journal Article
Oncology reports, ISSN 1021-335X, 04/2015, Volume 33, Issue 4, pp. 1976 - 1984
Dietary agents | DNMT3β | Reactivation | Epigenetic | HDAC1 | EGCG | Life Sciences & Biomedicine | Oncology | Science & Technology | DNA (Cytosine-5-)-Methyltransferases - physiology | Humans | Uterine Cervical Neoplasms - pathology | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Chromatin Assembly and Disassembly - drug effects | Genes, Tumor Suppressor - drug effects | RNA, Messenger - biosynthesis | Tumor Suppressor Proteins - genetics | Enzyme Induction - drug effects | Female | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Catechin - pharmacology | Neoplasm Proteins - genetics | Anticarcinogenic Agents - pharmacology | Histone Deacetylase 1 - genetics | DNA (Cytosine-5-)-Methyltransferases - biosynthesis | Neoplasm Proteins - biosynthesis | Models, Molecular | Histone Deacetylase 1 - biosynthesis | Uterine Cervical Neoplasms - genetics | DNA (Cytosine-5-)-Methyltransferases - genetics | RNA, Neoplasm - biosynthesis | Histone Deacetylase Inhibitors - pharmacology | Protein Conformation | Catechin - analogs & derivatives | Molecular Docking Simulation | HeLa Cells | Histone Deacetylases - physiology | Tumor Suppressor Proteins - biosynthesis | DNA Methylation - drug effects | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 03/2016, Volume 76, Issue 6, pp. 1494 - 1505
Life Sciences & Biomedicine | Oncology | Science & Technology | Colonic Neoplasms - genetics | Gene Silencing - drug effects | Calcium - metabolism | CpG Islands - drug effects | Colonic Neoplasms - drug therapy | Humans | Promoter Regions, Genetic - drug effects | Promoter Regions, Genetic - genetics | Genes, Tumor Suppressor - drug effects | Epigenomics - methods | HEK293 Cells | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Cell Line | HCT116 Cells | DNA Methylation - genetics | Signal Transduction - genetics | Signal Transduction - drug effects | Calcium Signaling - drug effects | Epigenesis, Genetic - genetics | K562 Cells | Cell Line, Tumor | CpG Islands - genetics | HL-60 Cells | Histone Deacetylase Inhibitors - pharmacology | Calcium Signaling - genetics | DNA Methylation - drug effects | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 12/2008, Volume 118, Issue 12, pp. 3917 - 3929
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Protein Kinases - metabolism | Neoplasm Transplantation | Protein Kinases - genetics | Antibiotics, Antineoplastic - pharmacology | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Ovarian Neoplasms - pathology | Cell Survival - genetics | Transplantation, Heterologous | Phosphatidylinositol 3-Kinases - metabolism | Autophagy - drug effects | Ovarian Neoplasms - genetics | Chloroquine - pharmacology | Cysteine Endopeptidases - metabolism | Tumor Suppressor Proteins - genetics | Female | Ovarian Neoplasms - metabolism | Antirheumatic Agents - pharmacology | Autophagy - genetics | Cell Survival - drug effects | Tumor Suppressor Proteins - metabolism | rho GTP-Binding Proteins - genetics | Phagosomes - metabolism | Sirolimus - pharmacology | Genomic Imprinting - drug effects | Genomic Imprinting - genetics | Phosphatidylinositol 3-Kinases - genetics | Animals | Intercellular Signaling Peptides and Proteins - pharmacology | Mice, Nude | Cysteine Endopeptidases - genetics | rho GTP-Binding Proteins - metabolism | Cell Line, Tumor | Mice | Mice, Inbred BALB C | TOR Serine-Threonine Kinases | Phagosomes - genetics | Care and treatment | Causes of | Physiological aspects | Tumor suppressor genes | Genetic aspects | Research | Health aspects | Apoptosis | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 06/2018, Volume 37, Issue 23, pp. 3045 - 3057
Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Calcium-Binding Proteins - metabolism | Lung Neoplasms - genetics | AMP-Activated Protein Kinases - metabolism | Phosphorylation | Humans | Protein-Serine-Threonine Kinases - genetics | Peutz-Jeghers Syndrome - genetics | Lignans - pharmacology | Ubiquitination | Lysosomes - metabolism | Biphenyl Compounds - pharmacology | Sumoylation | Gene Expression Regulation, Neoplastic - drug effects | Mutation | Genes, Tumor Suppressor | Protein-Serine-Threonine Kinases - metabolism | Calcium-Binding Proteins - genetics | Tumor suppressor genes | Genetic aspects | Gene mutations | Health aspects | Phosphotransferases | Carcinogenesis | Cell proliferation | Cell survival | Threonine | Lung cancer | Homeostasis | Kinases | Peutz-Jeghers syndrome | Cell adhesion & migration | Energy balance | LKB1 protein | Intestine | Polarity | Protein-serine/threonine kinase | Localization | Polyps | Cell migration | Tumors | Index Medicus
Journal Article